Phase Ib/II Clinical Trial of Pembrolizumab With Bevacizumab for Metastatic Renal Cell Carcinoma: BTCRC-GU14-003
帕博利珠单抗联合贝伐单抗治疗转移性肾细胞癌的 Ib/II 期临床试验：BTCRC-GU14-003
期刊:Journal of Clinical Oncology
影响因子:42.1
doi:10.1200/JCO.19.02394
Arkadiusz Z Dudek, Li C Liu, Shilpa Gupta, Theodore F Logan, Eric A Singer, Monika Joshi, Yousef N Zakharia, Joshua M Lang, James K Schwarz, Anas Al-Janadi, Ajjai S Alva
